Immunovant, Inc. IMVT Cash ratio
Cash ratio at other companies
Other financials
Where this comes from
Calculated from Immunovant, Inc.’s reported figures.
Based on the most recent quarter.
The official record: Immunovant, Inc.’s 10-K, filed May 20, 2026, on SEC EDGAR. View the filing →
Ask your AI about Immunovant, Inc.'s cash ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Immunovant, Inc.'s cash ratio?
- Immunovant, Inc. (IMVT) reported cash ratio of 8.6× in Q1 2026.
- How has Immunovant, Inc.'s cash ratio changed year-over-year?
- Immunovant, Inc.'s cash ratio decreased by 16.8% year-over-year, from 10.4× to 8.6×.
- What is the long-term trend for Immunovant, Inc.'s cash ratio?
- Over 5 years (2021 to 2026), Immunovant, Inc.'s cash ratio has grown at a -16.5% compound annual growth rate (CAGR), from 21.3× to 8.6×.
- What does cash ratio mean?
- Cash and equivalents divided by current liabilities at the quarter end. The most conservative liquidity measure — what the company could pay immediately with cash on hand.